InvestorsHub Logo
Followers 31
Posts 5913
Boards Moderated 0
Alias Born 04/20/2010

Re: alphapuppy post# 645484

Monday, 11/06/2023 10:55:03 AM

Monday, November 06, 2023 10:55:03 AM

Post# of 708369
You can't be serious. You spent a lot of posts trying to prove PFS was gonna be a winner.

This you?

Alphapuppy previous musings on primary PFS

My best-educated hypothesis is that clearly, the DCVax-L trial is going to return a positive result on the primary end point



The nice thing about this PFS review also is that there is no crossover effect between the curves such as could occur with my prior overall survival analysis OS.



Remember the preliminary results from 2018?

From that text:

The study’s primary endpoint is PFS, and the secondary endpoint is OS.



Or you could go to the history of the clinicaltrials.gov page for DCvax.

Guess we can toss out your opinion since you don't even remember your own BS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News